USFDA gives EIR to Aurobindo Pharma for its AP facility

It was inspected by the USFDA in February 2019 and issued a warning letter in June 2019.

299
USFDA Inspection
USFDA Inspection

Last Updated on October 2, 2024 by The Health Master

New Delhi: Aurobindo Pharma Ltd. said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in Andhra Pradesh.

The company’s Unit XI at Pydibhimavaram is an API non-antibiotic manufacturing facility.

It was inspected by the US Food and Drug Administration (USFDA) in February 2019 and issued a warning letter in June 2019.

It was inspected further by the USFDA from July 25 to August 2, 2022, and Form 483 was issued with three observations.

Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator has observed any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.

“Subsequent to our responses for the aforesaid observations, we have received an EIR classifying the inspection as Voluntary Action Indicated (VAI) from the USFDA, and with this, the inspection at our Unit XI is concluded,” Aurobindo Pharma said in a regulatory filing.

As per the USFDA, a VAI classification is given when objectionable conditions were found and documented during the inspection, but the agency is not prepared to take or recommend regulatory action.

USFDA issues warning letter to Lupin

USFDA gives final approval for Cyclophosphamide capsules

USFDA issues Form 483 with 3 Observations to Alkem

USFDA gives nod to market this generic Antibiotic Drug

USFDA issued OAI Status to Sun Pharma

USFDA gives tentative approval for Drospirenone tablets

Maha FDA to take action against bodybuilders involved in misuse of prescription drugs

Altering the contents of formulation without changing brand names

USFDA issues warning letter to Lupin

Dr VG Somani gets another three-month extension for his post as DCGI

Govt dissolves Odisha State Pharmacy Council

High Court asks Govt to re-examine Johnson & Johnson baby powder sample

Largest Pharma cluster in World to be launched in Telangana

NLEM: Anti-diabetes drugs and patented antivirals to get cheaper

First EC meeting of DCOIWA held at pink city Jaipur

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news